Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

CD317 (also called BST2 or HM1), a membrane protein of previously unknown function, is identified as a tetherin andhibition of Vpu function and consequent mobilization of tetherin’s antiviral activity is a potential therapeutic strategy in HIV/AIDS.